ID 205199033 · FY 2017–2023 · 7 years
Subsidiary of ეპა (90.0%)
Georgian pharmacy/pharmaceutical distribution company.
curated 2026-06-03reportal.ge
| Line item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | CAGR |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 46,519 | 50,112 | 35,960 | 40,348 | 54,693 | 65,463 | 61,646 | +4.8% |
| Total COGS | -37,017 | -38,931 | -27,865 | -33,816 | -46,935 | -53,078 | -52,825 | +6.1% |
| Gross Profit | 9,502 | 11,180 | 8,095 | 6,532 | 7,758 | 12,385 | 8,821 | -1.2% |
| Gross Margin | 20.4% | 22.3% | 22.5% | 16.2% | 14.2% | 18.9% | 14.3% | |
| Total Operating Expenses | -3,196 | -8,036 | -6,035 | -7,462 | -10,972 | -15,044 | -20,493 | +36.3% |
| EBITDA | 6,306 | 3,145 | 2,061 | -930 | -3,213 | -2,659 | -11,672 | nmf |
| EBITDA Margin | 13.6% | 6.3% | 5.7% | -2.3% | -5.9% | -4.1% | -18.9% | |
| Total D&A | -350 | -390 | -227 | -292 | -508 | -664 | -983 | +18.8% |
| EBIT / Operating Income | 5,957 | 2,754 | 1,834 | -1,222 | -3,722 | -3,323 | -12,655 | nmf |
| Total Interest Income | 0 | 22 | 48 | 158 | 0 | 0 | 0 | nmf |
| Total Interest Expense | -385 | -368 | -456 | -1,127 | -1,379 | -1,451 | -1,736 | +28.5% |
| Total Other Income | 0 | -98 | -194 | -860 | 3,866 | 1,641 | 3,150 | nmf |
| Profit Before Tax | 5,572 | 2,310 | 1,232 | -3,051 | -1,235 | -3,133 | -11,241 | nmf |
| Total Income Tax | 0 | 0 | 0 | -30 | 0 | 0 | -2 | -58.5% |
| Net Profit / (Loss) | 1,460 | 2,290 | 1,044 | -3,296 | -1,621 | -3,133 | -11,243 | nmf |
| Net Margin | 3.1% | 4.6% | 2.9% | -8.2% | -3.0% | -4.8% | -18.2% |
Ownership & directors from companyinfo.ge (public corporate registry).